Azenta Inc (AZTA) News

Form SD - Specialized disclosure report

Azenta to Participate in the Jefferies Global Healthcare Conference

Azenta to Participate in the Jefferies Global Healthcare Conference PR Newswire BURLINGTON, Mass., May 23...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK

Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK PR Newswire BURLINGTON, Mass., May 13...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Azenta Announces CEO Succession Plan

Azenta Announces CEO Succession Plan PR Newswire BURLINGTON, Mass., May 8, 2024 CEO Dr. Stephen Schwartz to...

Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024

Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 PR Newswire BURLINGTON, Mass., May...

Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast

Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast PR Newswire BURLINGTON...

Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report

Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report PR Newswire BURLINGTON, Mass...

Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference PR Newswire BURLINGTON, Mass...

Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum

Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum PR Newswire BURLINGTON...

Form 4 - Statement of changes in beneficial ownership of securities